BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 36325677)

  • 1. Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life.
    Balayssac D; Kerckhove N; Selvy M; Pereira B; Gonneau C; Pétorin C; Vimal-Baguet A; Melnikov S; Kullab S; Hebbar M; Bouché O; Slimano F; Bourgeois V; Lebrun-Ly V; Thuillier F; Mazard T; Tavan D; Benmammar KE; Monange B; Ramdani M; Péré-Vergé D; Huet-Penz F; Bedjaoui A; Genty F; Leyronnas C; Pezet D; Martin V
    Support Care Cancer; 2024 Jun; 32(7):427. PubMed ID: 38869647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of clinical and patient factors with chemotherapy-induced peripheral neuropathy (CIPN) in colorectal cancer: secondary analysis of the SCOT trial.
    Lemanska A; Harkin A; Iveson T; Kelly C; Saunders M; Faithfull S
    ESMO Open; 2023 Dec; 8(6):102063. PubMed ID: 37988949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture.
    Rostock M; Jaroslawski K; Guethlin C; Ludtke R; Schröder S; Bartsch HH
    Evid Based Complement Alternat Med; 2013; 2013():349653. PubMed ID: 24066010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study.
    Iivanainen S; Ravichandra R; Jekunen A; Arokoski R; Mentu S; Lang L; Ekström J; Virtanen H; Kataja V; Koivunen JP
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):6875-6882. PubMed ID: 36809503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises.
    Schönsteiner SS; Bauder Mißbach H; Benner A; Mack S; Hamel T; Orth M; Landwehrmeyer B; Süßmuth SD; Geitner C; Mayer-Steinacker R; Riester A; Prokein A; Erhardt E; Kunecki J; Eisenschink AM; Rawer R; Döhner H; Kirchner E; Schlenk RF
    Exp Hematol Oncol; 2017; 6():5. PubMed ID: 28194306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-pharmacological therapy for chemotherapy-induced peripheral neurotoxicity: a network meta-analysis of randomized controlled trials.
    Zhang X; Wang A; Wang M; Li G; Wei Q
    BMC Neurol; 2023 Dec; 23(1):433. PubMed ID: 38082216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced acupuncture therapy for radiotherapy-related neuropathic pain in patients with gynecologic cancer: a report of two cases and brief review.
    Dan-Feng Z; Jian-Cheng R; Shu-Zhen Z; Kun Z; Hong-Zhi Y; Lian-Sheng Y; Chun-Zhi T
    Front Neurol; 2023; 14():1163990. PubMed ID: 37351267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.
    Teng C; Cohen J; Egger S; Blinman PL; Vardy JL
    Support Care Cancer; 2022 Jan; 30(1):33-47. PubMed ID: 34410459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca
    Karlsson JOG; Jynge P
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial.
    Chan K; Lui L; Lam Y; Yu K; Lau K; Lai M; Lau W; Tai L; Mak C; Bian Z; Zhong LL
    Acupunct Med; 2023 Oct; 41(5):268-283. PubMed ID: 36325677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial.
    Chan K; Lui L; Yu K; Lau K; Lai M; Lau W; Ng B; Zhong LLD; Bian ZX
    Trials; 2020 Jan; 21(1):58. PubMed ID: 31918748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
    Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
    BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial.
    Kim JH; Kim EJ; Seo BK; Lee S; Lee S; Jung SY; Lee MH; Kim AR; Park HJ; Shin MS; Choi SM
    Trials; 2013 Aug; 14():254. PubMed ID: 23945074
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.